| 29.24 Data as of May 22 |  +2.19 / +8.10%Today’s Change | 26.26 Today|||52-Week Range 38.60 | +6.37% Year-to-Date |
| Previous close | 27.05 |
| Today’s open | 29.54 |
| Day’s range | 29.24 - 29.54 |
| Volume | 500 |
| Average volume (3 months) | 651 |
| Market cap | $1.6B |
| Dividend yield | -- |
| Earnings growth (last year) | -162.49% |
| Earnings growth (this year) | +20.44% |
| Earnings growth (next 5 years) | -176.50% |
| Revenue growth (last year) | +96.78% |
| P/E ratio | -- |
| Price/Sales | 62.39 |
| Price/Book | 3.15 |
| No competitors data available. |
| Next reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $28.8M |
| Annual profit (last year) | -$73.9M |
| Net profit margin | -257.00% |
Sector Health Technology |
Industry Biotechnology |
Chief Executive Officer & Executive Director Silviu Itescu, MBBS |
Chief Operating Officer Paul Rennie |
Corporate headquarters Melbourne, Victoria (vic) |
.
